Nanalysis Scientific (CVE:NSCI) Sets New 1-Year Low – Here’s What Happened

Nanalysis Scientific Corp. (CVE:NSCI)’s stock price reached a new 52-week low on Tuesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 43618 shares changing hands. The stock had previously closed at C$0.13.

Nanalysis Scientific Stock Performance

The firm has a market capitalization of C$16.08 million, a PE ratio of -1.40 and a beta of -0.75. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11. The stock has a 50-day moving average price of C$0.15 and a 200-day moving average price of C$0.17.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.